PB 58 of 2020
National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 5)
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health make the following determination.
Dated 29th June 2020
Thea Daniel
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Contents
1...... Name
2...... Commencement............................................................................................................................... 1
3...... Authority......................................................................................................................................... 1
4 ..... Schedule.......................................................................................................................................... 1
Schedule 1—Amendments 2
National Health (Continued Dispensing - Emergency Measures) Determination 2020 2
1 Name
(1) This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No.5).
(2) This instrument may also be cited as PB 58 of 2020.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information |
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 July 2020. | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 89A(3) of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Continued Dispensing – Emergency Measures) Determination 2020
[1] Schedule 1, entry for Aspirin
omit:
| | Tablet, dispersible, 300 mg | Oral |
[2] Schedule 1, entry for Diazepam
omit:
| | Injection 10 mg in 2 mL | Injection |
[3] Schedule 1, entry for Heparin
omit:
| | Injection 35,000 units (as sodium) in 35 mL | Injection |
[4] Schedule 1, omit entry for Idarubicin
[5] Schedule 1, entry for Levodopa with carbidopa
omit:
| | Tablet 250 mg‑25 mg (USP) | Oral |
[6] Schedule 1, entry for Ondansetron
omit:
| | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection |
| | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection |
[7] Schedule 1, entry for Phenelzine
omit:
| | Tablet 15 mg (as sulfate) (USP) | Oral |
[8] Schedule 1, omit entry for Prasugrel
[9] Schedule 1, after entry for Selegiline
insert:
| Semaglutide | Solution for injection 2 mg in 1.5 mL pre-filled pen | Injection |
| | Solution for injection 4 mg in 3 mL pre-filled pen | Injection |
[10] Schedule 1, entry for Whey protein formula supplemented with amino acids, long chain polyunsaturated fatty acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose
omit:
| | Sachets containing oral powder 100 g, 10 (RenaStart) | Oral |